-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Bionik Laboratories Corp. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q3 2022 to Q1 2023.
- Bionik Laboratories Corp. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Mar 2023 was $38.2K.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)